Hepatology

Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.

In this video, Tien Sy Dong, MD, PhD, from the University of California at Los Angeles, discusses his research on how bariatric surgery can alter the microbiome of certain patients with fatty liver disease...

He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...

In this video, Bruce Given, MD, discusses how alpha-1 antitrypsin deficiency can lead to cirrhosis and hepatocellular carcinoma.

David R. Nelson, MD, discusses future developments to HCV treatment strategies and methods, and how they will affect the standard of care.